Current Lipid Management Guidelines in Atherosclerotic Cardiovascular Disease

The use of coronary artery calcium (CAC) score to reclassify risk individuals at either borderline or intermediate risk, for whom the danger of statin therapy is unknown, is another significant addition to the 2018 recommendations. Increased risk of recurrent cardiovascular (CV) events is linked to having established atherosclerotic cardiovascular disease (ASCVD). Many modifiable risk factors for cardiovascular disease have been connected in the literature, including blood pressure, low-density lipoprotein (LDL), high-density lipoprotein (HDL), glucose intolerance, and smoking. High dose statins and strict adherence to dietary and lifestyle changes have been shown to reduce the risk of coronary events, with the advent of newer lipid-lowering medications, statins may one day become obsolete.